312 related articles for article (PubMed ID: 33207783)
1. Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target.
Caciolla J; Bisi A; Belluti F; Rampa A; Gobbi S
Molecules; 2020 Nov; 25(22):. PubMed ID: 33207783
[TBL] [Abstract][Full Text] [Related]
2. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
[TBL] [Abstract][Full Text] [Related]
3. Aromatase, aromatase inhibitors, and breast cancer.
Chumsri S; Howes T; Bao T; Sabnis G; Brodie A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):13-22. PubMed ID: 21335088
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal aromatase inhibitors for the treatment of breast cancer: an update.
Gobbi S; Rampa A; Belluti F; Bisi A
Anticancer Agents Med Chem; 2014 Jan; 14(1):54-65. PubMed ID: 23869785
[TBL] [Abstract][Full Text] [Related]
6. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Jordan VC; Brodie AM
Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
[TBL] [Abstract][Full Text] [Related]
7. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Saha T; Makar S; Swetha R; Gutti G; Singh SK
Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
[TBL] [Abstract][Full Text] [Related]
8. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
[TBL] [Abstract][Full Text] [Related]
9. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
Jiao J; Xiang H; Liao Q
Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors in breast cancer.
Hiscox S; Davies EL; Barrett-Lee P
Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
[TBL] [Abstract][Full Text] [Related]
11. Dual Aromatase-Sulphatase Inhibitors (DASIs) for the Treatment of Hormone Dependent Breast Cancer.
Banjare L; Jain AK; Thareja S
Mini Rev Med Chem; 2021; 21(20):3144-3165. PubMed ID: 33463462
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors in the treatment of breast cancer.
Brueggemeier RW; Hackett JC; Diaz-Cruz ES
Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
[TBL] [Abstract][Full Text] [Related]
13. Understanding the mechanisms of aromatase inhibitor resistance.
Miller WR; Larionov AA
Breast Cancer Res; 2012 Jan; 14(1):201. PubMed ID: 22277572
[TBL] [Abstract][Full Text] [Related]
14. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
Adhikari N; Baidya SK; Jha T
Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
[TBL] [Abstract][Full Text] [Related]
15. Aromatase: the enzyme and its inhibition.
Banting L; Ahmed S
Anticancer Agents Med Chem; 2009 Jul; 9(6):627-41. PubMed ID: 19601746
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment.
Molehin D; Filleur S; Pruitt K
Mol Cell Endocrinol; 2021 Jul; 531():111321. PubMed ID: 33992735
[TBL] [Abstract][Full Text] [Related]
18. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
19. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women.
Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS
Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666
[TBL] [Abstract][Full Text] [Related]
20. [Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer].
Bershteĭn LM; Barchuk AS; Gershfel'd ED; Kovalevskiĭ AIu; Maksimov SIa; Danilova MA; Barash IuA; Meshkova IE; Moiseenko VM; Novik AV; Pozharisskiĭ KM; Semiglazov VF; Tsyrlina EV; Chernobrovkina AE
Vopr Onkol; 2007; 53(1):7-13. PubMed ID: 17649727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
